Developing Novel Therapeutic Agents Targeting NLRP3 Inflammasome Inhibition and Oxidative Stress Mitigation for Epilepsy and Neurodegenerative Disorders (P9-9.005)
Design and screening of small chalcone derivative based compounds for targeting NLRP3 inflammasome and ROS inhibition.
Authors
- Ram Sharma (ORCID: https://orcid.org/0000-0002-7485-1356)
- Pritam Thapa (ORCID: https://orcid.org/0000-0002-9195-2124)
- Inamul Haque (ORCID: https://orcid.org/0000-0002-1307-9446)
- Mukut Sharma
- Vikas Singh (ORCID: https://orcid.org/0000-0001-6951-6492)
Institutions
- Kansas City VA Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212045
- Citations
- 1
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.11